InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Khattar Jack A., Chief Executive Officer. Officer active across 2 companies, notably Supernus Pharmaceuticals, INC.. Cumulatively, 18 reports have been logged. Total volume traded: €35k. The latest transaction was filed on 9 October 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
12,500 shares
Common Stock
SEC:0001539937-26-000008·
12,500 shares
Common Stock
SEC:0001539937-26-000008:0·
US$2m81,250 shares@ US$21.87360.062% mcap45.6% of flow
Common Stock
SEC:0001628280-25-044830·
€2m81,250 shares@ €21.87360.062% mcap22.8% of flow
Common Stock
SEC:0001628280-25-044830:0·
US$48,9162,267 shares@ US$21.57760.0017% mcap1.3% of flow
Common Stock
SEC:0001539937-25-000028·
€48,9162,267 shares@ €21.57760.0017% mcap0.6% of flow
Common Stock
SEC:0001539937-25-000028:0·
US$1m53,785 shares@ US$21.56120.041% mcap29.7% of flow
Common Stock
SEC:0001539937-25-000026·
€1m53,785 shares@ €21.56120.041% mcap14.9% of flow
Common Stock
SEC:0001539937-25-000026:0·
US$248,13111,510 shares@ US$21.55790.0087% mcap6.4% of flow
Common Stock
SEC:0001539937-25-000024·
€248,13111,510 shares@ €21.55790.0087% mcap3.2% of flow
Common Stock
SEC:0001539937-25-000024:0·
US$667,74360,000 shares@ US$11.12910.023% mcap17.1% of flow
Common Stock
SEC:0001628280-25-039302·
€667,74360,000 shares@ €11.12910.023% mcap8.6% of flow
Common Stock
SEC:0001628280-25-039302:0·
10,750 shares
Common Stock
SEC:0001104659-22-037189:0·
060,000 shares0
Common Stock
SEC:0001104659-22-035103:0·
€17,3085,000 shares@ €3.4616100.0% of flow
Common Stock
SEC:0000899243-21-046980·
Ideal exit: 30 Aug 2022 (T+270)
€17,3085,000 shares@ €3.461650.0% of flow
Common Stock
SEC:0000899243-21-046980:0·
Ideal exit: 30 Aug 2022 (T+270)
040,000 shares0
Common Stock
SEC:0001104659-21-098285·
040,000 shares0
Common Stock
SEC:0001104659-21-098285:0·
18 of 18 declarations
About Khattar Jack A.
Khattar Jack A. is the Chief Executive Officer of SUPERNUS PHARMACEUTICALS, INC.
